BioSpace

Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers

Pfizer seals the deal with Metsera for $10 billion after Novo Nordisk bowed out; President Donald Trump welcomes executives from Novo and Eli Lilly to the White House to announce that the companies’ ...
BioPharma Dive

Corporate venture firms stepped in for drug startups during biotech funding pullback

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have been among the most active investors in biotech startups this year.

Inside the $15b hostile battle pitting Pfizer against Novo

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.
FIRSTonline

Novo Nordisk and Pfizer are competing for billions of dollars over Metsera, a drugmaker specializing in anti-obesity drugs.

The Danish and American companies have sensed the potential of the biotech company, which could help them recover. Pfizer is ...

Pfizer Gets Metsera: Why The $20.65 CVR Is Highly Likely To Pay Out (In Part)

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

Canadian Paralympic Committee and Pfizer Canada renew long-time partnership, will celebrate 30th anniversary in 2026

MONTREAL, Nov. 6, 2025 /CNW/ - The Canadian Paralympic Committee (CPC) and Pfizer Canada have extended their partnership, with 2026 marking 30 years of working together to support and promote ...